Thank you very much.
I have two more questions, including one for Mr. Doyle.
We know very well that supply management is on the table. The government has said so; a number of witnesses have said so as well. So even though this is our most stable and profitable agricultural sector for small communities, supply management is definitely on the table in current negotiations.
Your concern isn't just about the agreement, but also about the fact that it can have a kind of domino effect for other agreements that Canada will be negotiating, isn't it?
My final question I'll flip over to Mr. Clow, of Cavendish Farms.
Thank you for your presentation. We had this week a study come out by Paul Grootendorst and Aden Hollis, professors respectively in the Faculty of Pharmacy in the University of Toronto and the Department of Economics of the University of Calgary.
They say that the cost to the Canadian health care system of the CETA provisions on intellectual property will increase health costs by about $3 billion a year in Canada. Now, that will impact on the public health care system, but also on individuals and on private health care plans.
So I'm wondering whether, for Cavendish Farms, you have done any study of what your cost of doing business in your private health care plan will be for these provisions and for the direction the government is currently taking on negotiations.